Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza

by palligoelme@gmail.com | Oct 14, 2025 | Clinical Trials

​ Conditions: Influenza Infection; Infections; Respiratory Virus Infections; Respiratory Tract Infections; RNA Viruses; Orthomyxoviridae Infections; Viral Diseases Interventions: Biological: A/Mallard/Ohio-99/MM4/1989 H10N7 Sponsors: National Institute of Allergy and...

Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in Japan

by palligoelme@gmail.com | Oct 14, 2025 | Clinical Trials

​ Conditions: Immune Thrombocytopenia Interventions: Drug: rilzabrutinib Sponsors: Sanofi Not yet recruiting Conditions: Immune Thrombocytopenia Interventions: Drug: rilzabrutinib Sponsors: Sanofi Not yet recruiting 

Describing the Effect of Familiar Song on Arousal and Awareness for Children With Disorders of Consciousness (DoC)

by palligoelme@gmail.com | Oct 13, 2025 | Clinical Trials

​ Conditions: Disorder of Consciousness; Acquired Brain Injury Interventions: Behavioral: Live Music Therapy; Behavioral: Recorded Music Sponsors: Murdoch Childrens Research Institute Not yet recruiting Conditions: Disorder of Consciousness; Acquired Brain Injury...

Effects of Palmar Cooling on the Human Immune System

by palligoelme@gmail.com | Oct 10, 2025 | Clinical Trials

​ Conditions: Human Immune Response Interventions: Device: Palmar Temperature Control Device Sponsors: Stanford University; Wu Tsai Human Performance Alliance Completed Conditions: Human Immune Response Interventions: Device: Palmar Temperature Control Device...

Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants

by palligoelme@gmail.com | Oct 10, 2025 | Clinical Trials

​ Conditions: Healthy Volunteer Interventions: Drug: atirmociclib (PF-07220060) Sponsors: Pfizer Not yet recruiting Conditions: Healthy Volunteer Interventions: Drug: atirmociclib (PF-07220060) Sponsors: Pfizer Not yet...